126 related articles for article (PubMed ID: 36693491)
1. YAP1 suppression inhibits autophagy and improves the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma.
Gao Y; Peng Q; Li S; Zheng K; Gong Y; Xue Y; Liu Y; Lu J; Zhang Y; Shi X
Exp Cell Res; 2023 Mar; 424(1):113486. PubMed ID: 36693491
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin promotes the expression level of PD-L1 in the microenvironment of hepatocellular carcinoma through YAP1.
Li S; Ji J; Zhang Z; Peng Q; Hao L; Guo Y; Zhou W; Cui Q; Shi X
Mol Cell Biochem; 2020 Dec; 475(1-2):79-91. PubMed ID: 32761300
[TBL] [Abstract][Full Text] [Related]
3. Dihydroartemisinin breaks the positive feedback loop of YAP1 and GLUT1-mediated aerobic glycolysis to boost the CD8
Gao Y; Gong Y; Lu J; Yang Y; Zhang Y; Xiong Y; Shi X
Biochem Pharmacol; 2024 Jul; 225():116294. PubMed ID: 38754557
[TBL] [Abstract][Full Text] [Related]
4. Dihydroartemisinin inhibited interleukin-18 expression by decreasing YAP1 in hepatocellular carcinoma cells.
Gong Y; Peng Q; Gao Y; Yang J; Lu J; Zhang Y; Yang Y; Liang H; Yue Y; Shi X
Acta Histochem; 2023 May; 125(4):152040. PubMed ID: 37119608
[TBL] [Abstract][Full Text] [Related]
5. Dihydroartemisinin inhibited the Warburg effect through YAP1/SLC2A1 pathway in hepatocellular carcinoma.
Peng Q; Hao L; Guo Y; Zhang Z; Ji J; Xue Y; Liu Y; Li C; Lu J; Shi X
J Nat Med; 2023 Jan; 77(1):28-40. PubMed ID: 36068393
[TBL] [Abstract][Full Text] [Related]
6. SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET.
He Q; Lin Z; Wang Z; Huang W; Tian D; Liu M; Xia L
Oncogene; 2020 Dec; 39(50):7279-7295. PubMed ID: 33046796
[TBL] [Abstract][Full Text] [Related]
7. miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression.
Chen M; Wu L; Tu J; Zhao Z; Fan X; Mao J; Weng Q; Wu X; Huang L; Xu M; Ji J
EBioMedicine; 2018 Sep; 35():142-154. PubMed ID: 30111512
[TBL] [Abstract][Full Text] [Related]
8. Dihydroartemisinin broke the tumor immunosuppressive microenvironment by inhibiting YAP1 expression to enhance anti-PD-1 efficacy.
Peng Q; Li S; Shi X; Guo Y; Hao L; Zhang Z; Ji J; Zhao Y; Li C; Xue Y; Liu Y
Phytother Res; 2023 May; 37(5):1740-1753. PubMed ID: 36576358
[TBL] [Abstract][Full Text] [Related]
9. Dihydroartemisinin increased the abundance of Akkermansia muciniphila by YAP1 depression that sensitizes hepatocellular carcinoma to anti-PD-1 immunotherapy.
Zhang Z; Shi X; Ji J; Guo Y; Peng Q; Hao L; Xue Y; Liu Y; Li C; Lu J; Yu K
Front Med; 2023 Aug; 17(4):729-746. PubMed ID: 37121958
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA muskelin 1 antisense RNA (MKLN1-AS) is a potential diagnostic and prognostic biomarker and therapeutic target for hepatocellular carcinoma.
Guo C; Zhou S; Yi W; Yang P; Li O; Liu J; Peng C
Exp Mol Pathol; 2021 Jun; 120():104638. PubMed ID: 33878313
[TBL] [Abstract][Full Text] [Related]
11. Dihydroartemisinin reduced lipid droplet deposition by YAP1 to promote the anti-PD-1 effect in hepatocellular carcinoma.
Hao L; Guo Y; Peng Q; Zhang Z; Ji J; Liu Y; Xue Y; Li C; Zheng K; Shi X
Phytomedicine; 2022 Feb; 96():153913. PubMed ID: 35026515
[TBL] [Abstract][Full Text] [Related]
12. miR-199a-3p inhibits cell proliferation and induces apoptosis by targeting YAP1, suppressing Jagged1-Notch signaling in human hepatocellular carcinoma.
Ren K; Li T; Zhang W; Ren J; Li Z; Wu G
J Biomed Sci; 2016 Nov; 23(1):79. PubMed ID: 27832779
[TBL] [Abstract][Full Text] [Related]
13. Impaired degradation of YAP1 and IL6ST by chaperone-mediated autophagy promotes proliferation and migration of normal and hepatocellular carcinoma cells.
Desideri E; Castelli S; Dorard C; Toifl S; Grazi GL; Ciriolo MR; Baccarini M
Autophagy; 2023 Jan; 19(1):152-162. PubMed ID: 35435804
[TBL] [Abstract][Full Text] [Related]
14. Standard CD44 modulates YAP1 through a positive feedback loop in hepatocellular carcinoma.
Fan Z; Xia H; Xu H; Ma J; Zhou S; Hou W; Tang Q; Gong Q; Nie Y; Bi F
Biomed Pharmacother; 2018 Jul; 103():147-156. PubMed ID: 29649630
[TBL] [Abstract][Full Text] [Related]
15. miR-424-5p Regulates Hepatoma Cell Proliferation and Apoptosis.
Piao L; Wang F; Wang Y; Yang Z; Li Q; Cui L; Yu Q
Cancer Biother Radiopharm; 2019 Apr; 34(3):196-202. PubMed ID: 30676784
[TBL] [Abstract][Full Text] [Related]
16. Single-Cell RNA Sequencing Identifies Yes-Associated Protein 1-Dependent Hepatic Mesothelial Progenitors in Fibrolamellar Carcinoma.
Jewell ML; Gibson JR; Guy CD; Hyun J; Du K; Oh SH; Premont RT; Hsu DS; Ribar T; Gregory SG; Diehl AME
Am J Pathol; 2020 Jan; 190(1):93-107. PubMed ID: 31669305
[TBL] [Abstract][Full Text] [Related]
17. The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas.
Lee K; Lee KB; Jung HY; Yi NJ; Lee KW; Suh KS; Jang JJ
BMC Cancer; 2017 Jun; 17(1):441. PubMed ID: 28645247
[TBL] [Abstract][Full Text] [Related]
18. A curcumin derivative, WZ35, suppresses hepatocellular cancer cell growth via downregulating YAP-mediated autophagy.
Wang L; Zhu Z; Han L; Zhao L; Weng J; Yang H; Wu S; Chen K; Wu L; Chen T
Food Funct; 2019 Jun; 10(6):3748-3757. PubMed ID: 31172987
[TBL] [Abstract][Full Text] [Related]
19. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.
Zhou D; Conrad C; Xia F; Park JS; Payer B; Yin Y; Lauwers GY; Thasler W; Lee JT; Avruch J; Bardeesy N
Cancer Cell; 2009 Nov; 16(5):425-38. PubMed ID: 19878874
[TBL] [Abstract][Full Text] [Related]
20. Ovatodiolide suppresses yes-associated protein 1-modulated cancer stem cell phenotypes in highly malignant hepatocellular carcinoma and sensitizes cancer cells to chemotherapy in vitro.
Chang HL; Chen HA; Bamodu OA; Lee KF; Tzeng YM; Lee WH; Tsai JT
Toxicol In Vitro; 2018 Sep; 51():74-82. PubMed ID: 29698666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
